1. Home
  2. DRUG vs NCMI Comparison

DRUG vs NCMI Comparison

Compare DRUG & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$75.85

Market Cap

364.8M

Sector

Health Care

ML Signal

HOLD

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

HOLD

Current Price

$4.17

Market Cap

414.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRUG
NCMI
Founded
2019
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
364.8M
414.7M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
DRUG
NCMI
Price
$75.85
$4.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$83.00
$6.88
AVG Volume (30 Days)
193.8K
361.2K
Earning Date
12-30-2025
10-30-2025
Dividend Yield
N/A
2.88%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$236,300,000.00
Revenue This Year
N/A
$3.66
Revenue Next Year
N/A
$12.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.18
$3.81
52 Week High
$81.33
$7.60

Technical Indicators

Market Signals
Indicator
DRUG
NCMI
Relative Strength Index (RSI) 76.86 49.03
Support Level $69.12 $4.02
Resistance Level $75.99 $4.32
Average True Range (ATR) 4.20 0.15
MACD 1.55 0.01
Stochastic Oscillator 88.57 63.81

Price Performance

Historical Comparison
DRUG
NCMI

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: